Loading stock data...

Span Divergent Limited

BSE: SDL

BSE
20.94 0.99 (4.96%)

Prev Close

19.95

Open Price

20.94

Volume

145

Today Low / High

20.94 / 20.94

52 WK Low / High

19.01 / 39.15

Range

20 - 22

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 20.94, reflecting a change of 0.99 (4.96241%). The expected target range on the BSE is 20 - 22. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

08 Aug 20.10 4.48%
07 Aug 19.05 4.99%
06 Aug 19.61 -2.86%
05 Aug 19.52 0.00%
04 Aug 19.92 0.00%
01 Aug 21.06 -5.41%
31 Jul 21.95 -4.51%
28 Jul 21.85 0.46%
25 Jul 21.85 0.00%
24 Jul 21.35 2.34%
23 Jul 22.00 -0.68%
22 Jul 23.50 -2.13%
21 Jul 23.72 -0.46%

Span Divergent Limited Graph

Span Divergent Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Span Divergent Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 20.94, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 20.94 21.15 19.03 - 23.26
21.36 17.09 - 25.63
21.57 15.10 - 28.04
Bearish Scenario 20.94 20.73 18.66 - 22.80
20.52 16.42 - 24.63
20.31 14.22 - 26.41

Overview of Span Divergent Limited

ISIN

INE004E01016

Industry

Medical - Specialties

Vol.Avg

323

Market Cap

114,696,750

Last Dividend

0

Official Website

Visit Website

IPO Date

2002-07-03

DCF Diff

-68.33

DCF

103

Financial Ratios Every Investor Needs

Stock Dividend of SDL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2013-07-16 July 16, 13 0.5 0.5
2011-07-26 July 26, 11 1 1
2010-06-18 June 18, 10 1.25 2.5
2008-08-08 August 08, 08 1 2
2007-08-10 August 10, 07 0.9 1.8

Stock Rating Details for SDL

Metric Value Recommendation
Overall Rating B- Sell
DCF Score 5 Strong Buy
ROE Score 5 Strong Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 8.96 Cr 2.96 Cr 6.00 Cr 0.6697 0.00 Cr 0.00 Cr 3.70 Cr -0.92 Cr -2.33 0.55 Cr -0.1024
2024-03-31 12.33 Cr 3.40 Cr 8.93 Cr 0.7241 0.00 Cr 0.28 Cr -0.03 Cr 0.98 Cr 1.79 2.78 Cr 0.0791
2023-03-31 12.52 Cr 3.39 Cr 9.13 Cr 0.7293 0.00 Cr 0.30 Cr -0.92 Cr -5.05 Cr -9.25 -2.45 Cr -0.4036
2022-03-31 13.09 Cr 5.01 Cr 8.08 Cr 0.6174 0.00 Cr 0.32 Cr -1.74 Cr -9.80 Cr -17.94 -7.12 Cr -0.7488
2021-03-31 7.40 Cr 2.52 Cr 4.88 Cr 0.6591 0.00 Cr 0.38 Cr -5.35 Cr -5.59 Cr -10.23 -1.42 Cr -0.7546

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 1.04 Cr 23.20 Cr 32.04 Cr -2.8068 Cr 8.35 Cr 7.32 Cr 1.00 Cr 9.63 Cr 0.00 Cr 0.00 Cr 0.36 Cr 27.8945 Cr
2024-03-31 0.93 Cr 24.19 Cr 31.75 Cr -1.8874 Cr 9.11 Cr 8.19 Cr 1.18 Cr 10.73 Cr 0.00 Cr 0.00 Cr 0.50 Cr 27.0082 Cr
2023-03-31 0.40 Cr 25.59 Cr 33.95 Cr -2.8387 Cr 11.15 Cr 10.75 Cr 1.61 Cr 12.80 Cr 19.14 Cr 0.18 Cr 0.74 Cr 27.8492 Cr
2022-03-31 0.19 Cr 27.83 Cr 30.76 Cr 2.2208 Cr 13.19 Cr 13.00 Cr 1.78 Cr 14.71 Cr 14.15 Cr 0.64 Cr 0.37 Cr 23.1179 Cr
2021-03-31 0.71 Cr 34.44 Cr 27.22 Cr 12.0190 Cr 17.99 Cr 17.27 Cr 0.62 Cr 17.52 Cr 0.85 Cr 0.55 Cr 0.49 Cr 14.0572 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 1.8581 Cr -1.0481 Cr -1.1496 Cr 0.2382 Cr -0.3398 Cr 0.5853 Cr -1.6199 Cr -0.9173 Cr -0.5459 Cr 0.0000 Cr 0.1826 Cr
2024-03-31 2.5027 Cr 0.0561 Cr -2.0938 Cr 2.1202 Cr 0.5060 Cr 0.9251 Cr -0.3825 Cr 0.6508 Cr -1.3747 Cr 0.0000 Cr 0.4235 Cr
2023-03-31 1.9776 Cr 0.5311 Cr -2.3038 Cr 1.8030 Cr 0.2049 Cr 0.3990 Cr -0.1746 Cr -5.5215 Cr -1.3043 Cr 0.0000 Cr 0.3840 Cr
2022-03-31 7.0307 Cr -2.0528 Cr -5.4964 Cr 7.2910 Cr -0.5185 Cr 0.1941 Cr 0.2603 Cr -10.3691 Cr -4.3950 Cr -0.0210 Cr -1.1409 Cr
2021-03-31 -0.2120 Cr 1.9878 Cr -1.4072 Cr 0.1542 Cr 0.3686 Cr 0.7126 Cr 0.3662 Cr -6.1067 Cr 0.1711 Cr 0.0000 Cr 0.7714 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.55 Cr 0.40 Cr 0.15 Cr 0.2794 -0.45 Cr -0.89 Cr -1.87 -0.90 Cr -1.6159
2024-12-31 1.84 Cr 0.91 Cr 0.92 Cr 0.5029 -0.50 Cr -0.15 Cr -0.28 0.25 Cr -0.0828
2024-09-30 2.69 Cr 0.26 Cr 2.43 Cr 0.9024 -0.04 Cr 0.13 Cr 0.23 0.49 Cr 0.0469
2024-06-30 3.71 Cr 2.19 Cr 1.52 Cr 0.4085 -0.01 Cr -0.01 Cr -0.01 0.47 Cr -0.0015
2024-03-31 3.04 Cr 1.61 Cr 1.42 Cr 0.4688 -0.13 Cr 0.92 Cr 1.62 1.16 Cr 0.3038

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 1.04 Cr 6.30 Cr 7.34 Cr 1.39 Cr 1.00 Cr 12.38 Cr 9.63 Cr 23.20 Cr 32.04 Cr
2024-12-31 0.00 Cr 0.00 Cr 6.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 7.60 Cr
2024-09-30 0.43 Cr 6.41 Cr 6.84 Cr 0.00 Cr 0.62 Cr 12.22 Cr 9.82 Cr 23.33 Cr 30.93 Cr
2024-06-30 0.00 Cr 0.00 Cr 5.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 7.57 Cr
2024-03-31 0.93 Cr 4.69 Cr 5.61 Cr 1.61 Cr 1.18 Cr 12.07 Cr 10.73 Cr 24.19 Cr 31.75 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 -0.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.92 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2010-07-27 July 27, 10 2:1

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Chief Financial Officer & Executive Director
Mr. Paras B. Desai

Gender: male

Year Born: 1967

Chief Operating Officer
Ms. Sujata V. Desai

Gender: female

Year Born: 1973

Manager of Accounts
Mr. Minesh Mohanbhai Patel

Gender: male

Year Born: 1983

Founder & Chairman of the Board
Dr. Pradipkumar Keshavlal Desai

Gender: Not Specified

Year Born: 1939

MD & Executive Director
Mr. Viral Pradipkumar Desai

Gender: male

Year Born: 1968

Whole-Time Company Secretary & Compliance Officer
Ms. Urvi Tulesh Shinde

Gender: female

Year Born:

FAQs about Span Divergent Limited

Who is the CEO of the company?

The CEO is Pradipkumar Keshavlal Desai.

What is the current market price of the stock?

The current price is ₹21.00.

What is the 52-week price range?

The range is ₹19.01-39.15.

What is the market capitalization of the company?

The market capitalization is ₹11.47 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -10.85.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Span Divergent Limited (ISIN: INE004E01016) is a leading Medical - Specialties in India. With a market capitalization of ₹11.47 crores and an average daily volume of 323 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.